GISEA/OEG International Symposium 2017
←
→
Trascrizione del contenuto della pagina
Se il tuo browser non visualizza correttamente la pagina, ti preghiamo di leggere il contenuto della pagina quaggiù
GISEA/OEG FERRARA International Symposium 2017 2-3 MARZO 2017
GISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
SCIENTIFIC ORGANIZERS
Giovanni LAPADULA
President of GISEA
(Gruppo Italiano di Studio sulla Early Arthritis)
Bari (Italy)
Gianfranco FERRACCIOLI
President of OEG
(Osservatorio Epidemiologico GISEA)
Roma (Italy)
SCIENTIFIC COMMITTEE
Fabiola ATZENI - Milano (Italy)
Roberto CAPORALI - Pavia (Italy)
Ennio Giulio FAVALLI - Milano (Italy)
Marcello GOVONI - Ferrara (Italy)
Elisa GREMESE - Roma (Italy)
Florenzo IANNONE - Bari (Italy)
Fausto SALAFFI - Ancona (Italy)
Marco SEBASTIANI - Modena (Italy)
GISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
FACULTY
Federico BISCETTI Juan J. GOMEZ REINO
Roma (Italy) Santiago de Compostela (Spain)
Paolo BONARETTI Roberto GORLA
Reggio Emilia (Italy) Brescia (Italy)
Serena BUGATTI Walter GRASSI
Pavia (Italy) Jesi (Italy)
Luca CANTARINI Clive KELLY
Siena (Italy) Newcastle (UK)
Francesco Paolo CANTATORE Andreina MANFREDI
Foggia (Italy) Modena (Italy)
Antonio CARLETTO Anna Maria MARATA
Verona (Italy) Modena (Italy)
Marina CAROTTI Saverio MENNINI
Jesi (Italy) Roma (Italy)
Lorenzo CAVAGNA Carlo Maurizio MONTECUCCO
Pavia (Italy) Pavia (Italy)
Stefania CERRI Ignazio Benedetto OLIVIERI
Modena (Italy) Potenza (Italy)
Luca CIMINO Giuseppe PASSIU
Reggio Emilia (Italy) Sassari (Italy)
Fabrizio CONTI Raffaele PELLERITO
Roma (Italy) Torino (Italy)
Andrea DORIA Maria Beatrice PRINCIPI
Padova (Italy) Bari (Italy)
Oscar Massimiliano EPIS Leonardo PUNZI
Milano (Italy) Padova (Italy)
Caterina FERRELI Roberta RAMONDA
Cagliari (Italy) Padova (Italy)
Clodoveo FERRI Maurizio ROSSINI
Modena (Italy) Verona (Italy)
Rosario FOTI Carlo SALVARANI
Catania (Italy) Reggio Emilia (Italy)
Enrico FUSARO Piercarlo SARZI PUTTINI
Torino (Italy) Milano (Italy)
Rosario GAGLIARDI Luigi SINIGAGLIA
Lecce (Italy) Milano (Italy)
Mauro GALEAZZI Anja STRANGFELD
Siena (Italy) Mannheim (Germany)
James GALLOWAY Giovanni TRIOLO
London (UK) Palermo (Italy)
Francesco TROTTA
Ferrara (Italy)
GISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
SUMMARY TABLE - THURSDAY 2TH MARCH
SCIENTIFIC ECM PROGRAM SPONSORED LECTURE CORSI MONOTEMATICI
09,00 – 10,30 Sessione Corsi Monotematici No ECM
La Medicina Comunicazionale
Imaging del Paziente Complesso
10,30 – 11,00 Sponsored Lecture - MSD
Golimumab persistence in therapy in real life: new evidences from Italian registries
11,00 – 11,30 Sponsored Lecture - BMS
Efficacia di abatacept nella pratica clinica
11,30 – 11,40 Apertura
SESSION I
Comorbidities in Rheumatoid Arthritis: Skeletal Health
11,40 – 12,00 Rheumatoid arthritis: systemic osteoporosis and fragility fractures.
12,00 – 12,20 Pathophysiology of subchondral bone erosions in rheumatoid arthritis.
12,20 – 12,40 Therapeutic options to preserve bone health in rheumatoid arthritis.
12,40 – 12,50 Discussion
12,50 – 13,20 Lettura
Nuove Terapie: Jakinibs
13,20 – 14,15 Lunch
SESSION II
Infections
14,15 – 14,35 TB infections in patients with RA treated with biological agents:
results from the British Register.
14,35 – 14,55 Outcome of serious infections in RA patients:
results from the German Biologics Register.
14,55 – 15,15 Non-specific infections in patients with RA and SpA treated with biological agents.
15,15 – 15,30 Discussion
GISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
SUMMARY TABLE - THURSDAY 2TH MARCH
15,30 – 16,00 Sponsored Lecture - SANOFI
Quando l’anti-TNF in prima linea fallisce, quali sono le possibili scelte
da intraprendere nel paziente affetto da AR (Artrite reumatoide)
16,00 – 16,30 Sponsored Lecture - ABBVIE
Occhio alle spondiloartropatie
SESSION III
Cardiovascular Risks
16,30 – 16,50 Corticosteroids and biotechnologic drugs in disease control and CV risk:
which side hangs the balance?
16,50 – 17,10 Thromboembolic risk and stroke in inflammatory arthritides.
17,10 – 17,25 Discussion
17,25 – 17,55 Sponsored Lecture - CELGENE
La gestione del paziente con artrite psoriasica in assenza di fattori
di prognosi severa
SESSION IV
Impact on the Neurologic System
17,55 – 18,15 Peripheral neuropathy in rheumatoid arthritis: a neglected comorbidity.
18,15 – 18,35 Central nervous system and rheumatoid arthritis:
not only atloepistrophic involvement.
18,35 – 18,55 Drugs and neurologic involvement in rheumatoid arthritis: myth or reality?
18.45 – 19.10 Discussion
SCIENTIFIC ECM PROGRAM
SPONSORED LECTURE
CORSI MONOTEMATICI
GISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
SUMMARY TABLE - FRIDAY 3TH MARCH
SCIENTIFIC ECM PROGRAM SPONSORED LECTURE CORSI MONOTEMATICI
09,00 – 09,30 Sponsored Lecture - PFIZER
An innovative management of unmet needs in RA (rheumatoid arthritis)
patients to achieve a Comprehensive Disease Control
09,30 – 10,00 Sponsored Lecture - ROCHE
IL-6 inhibition in RA: tocilizumab from RCT to real world data.
SESSION V
Lung Diseases
10,00 – 10,20 The need for an early diagnosis of Rheumatoid Arthritis
related Interstitial Lung Disease.
10,20 – 10,40 Clinical assessment of Rheumatoid Arthritis related Interstitial Lung Disease.
10,40 – 11,00 Conventional and biological DMARDs and Rheumatoid Arthritis related Interstitial
Lung Disease: the problem or the solution?
11,00 – 11,15 Discussion
11,15 – 11,45 Presentazione Progetto Patient Profiling
TAVOLA ROTONDA
Which future for public health care sustainability?
Regional scenarios, clinical needs and working hypothesis
11,45 – 12,05 National health care system and regional scenarios.
12,05 – 12,25 Clinical needs and expectancies.
12,25 – 12,45 Are there suitable working hypothesis solutions ?
12,45 – 13,15 Sponsored Lecture - NOVARTIS
Secukinumab: tra la real life e i dati registrativi
13,15 - 13,45 Sponsored Lecture - BIOGEN
Sostenibilità delle innovazioni farmacologiche : i biosimilari”
13,45 – 14,30 Lunch
GISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
SUMMARY TABLE - FRIDAY 3TH MARCH
SESSION VI
Skin: a “Window of Opportunity”
14,30 – 14,50 Il Progetto IDEA: final report
14,50 – 15,20 Lettura
PsA e obesità.
15,20- 15,40 Skin and Psoriatic Arthritis
15,40 – 16,00 Skin and Inflammatory Bowel Diseases
16,00 – 16,20 Skin and Rare Diseases
16,20 – 16,35 Discussion
ECM TEST
SCIENTIFIC ECM PROGRAM
SPONSORED LECTURE
CORSI MONOTEMATICI
GISEA/OEG FERRARA International Symposium 2017 2-3 MARZO 2017 EDUCATIONAL AIMS A number of European countries have set-up biologics registries to follow cohorts of patients treated with therapies targeting molecules, at extra-cellular and intracellular level either, which play a pivotal role in the pathogenesis of RA and Spondyloarthrtis, and record their characteristics and clinical course over time. As we are aware, these registries have begun to provide valuable insights into the optimal treatment of various rheumatic conditions that can and should be used to inform clinical decision making and to provide also important safety informations. The educational aims of this congress are to: • Highlight the role of national biologic registers as a source of long-term, real-life data and assess the implications for clinical practice • Review the long-term effectiveness and maintenance on therapy data from national biologic registers • Comparing data from national biologic registers on RA and Spondyloarthritides • To stress the value of early diagnosis and treatments • Reanalyze the ultrasonography as a useful diagnostic tool in managing these diseases. • Consider the safety data emerging from national biologic registers with a particular focus on serious infections, lymphoma and solid tumors. LOCATION The GISEA/OEG International Symposium 2017 will be held at the Aula Magna of the University of Ferrara, situated in: 37 Corso Ercole I d’Este, Ferrara (FE), Zip Code 44121. This marvellous building has been technologically updated in order to hold a number of conferences, conventions and events, while retaining its classical look. It is situated in the City Centre of Ferrara, surrounded by parks, and in close proximity to parking garages, restaurants, bars, and more.
GISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
ECM PROGRAM
THURSDAY 2TH MARCH
11,30 – 11,40 Apertura
SESSION I
Comorbidities in Rheumatoid Arthritis
Skeletal Health
CHAIRMEN: Francesco Paolo Cantatore,
Carlo Salvarani, Ennio Giulio Favalli
11,40 – 12,00 Rheumatoid arthritis: systemic osteoporosis
and fragility fractures.
Luigi Sinigaglia, Milano
12,00 – 12,20 Pathophysiology of subchondral bone erosions
in rheumatoid arthritis.
Serena Bugatti, Pavia
12,20 – 12,40 Therapeutic options to preserve bone health
in rheumatoid arthritis.
Maurizio Rossini, Verona
12,40 – 12,50 Discussion
12,50 – 13,20 Lettura
Nuove Terapie: Jakinibs
SPEAKER: Luigi Sinigaglia, Milano
CHAIRMEN: Giovanni Lapadula
13,20 – 14,15 LUNCHGISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
ECM PROGRAM
SESSION II
Infections
CHAIRMEN: Piercarlo Sarzi-Puttini - Fabiola Atzeni
14,15 – 14,35 TB infections in patients with RA treated
with biological agents: results from the British Register.
James Galloway, U.K.
14,35 – 14,55 Outcome of serious infections in RA patients:
results from the German Biologics Register.
Anja Strangfeld, Germany
14,55 – 15,15 Non-specific infections in patients with RA
and SpA treated with biological agents.
Juan Josè Gomez Reino, Spain
15,15 – 15,30 Discussion
SESSION III
Cardiovascular Risks
CHAIRMEN:
Florenzo Iannone, Marco Sebastiani, Elisa Gremese
16,30 – 16,50 Corticosteroids and biotechnologic drugs in disease
control and CV risk: which side hangs the balance?
Fabiola Atzeni, Milano
16,50-17,10 Thromboembolic risk and stroke in inflammatory arthritides.
Federico Biscetti, Roma
17,10 – 17,25 DiscussionGISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
ECM PROGRAM
SESSION IV
Impact on the Neurologic System
CHAIRMEN:
Mauro Galeazzi, Antonio Carletto, Roberto Caporali
17,55 – 18,15 Peripheral neuropathy in rheumatoid arthritis:
a neglected comorbidity.
Lorenzo Cavagna, Pavia
18,15 – 18,35 Central nervous system and rheumatoid arthritis:
not only atloepistrophic involvement.
Marcello Govoni, Ferrara
18,35 – 18,55 Drugs and neurologic involvement in rheumatoid arthritis:
myth or reality?
Fabrizio Conti, Roma
18.45 – 19.10 DiscussionGISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
ECM PROGRAM
FRIDAY 3TH MARCH
SESSION V
Lung Diseases
CHAIRMEN: Andrea Doria, Roberto Gorla, Clodoveo Ferri
10,00 – 10,20 The need for an early diagnosis of Rheumatoid Arthritis
related Interstitial Lung Disease.
Andreina Manfredi, Modena
10,20 – 10,40 Clinical assessment of Rheumatoid Arthritis
related Interstitial Lung Disease.
Stefania Cerri, Modena
10,40 – 11,00 Conventional and biological DMARDs
and Rheumatoid Arthritis related Interstitial Lung Disease:
the problem or the solution?
Clive Kelly, Newcastle (U.K.)
11,00 – 11,15 Discussion
11,15 – 11,45 Presentazione Progetto Patient Profiling
SPEAKER: Ennio Giulio Favalli, Milano
CHAIRMEN: Giovanni Lapadula, Gianfranco Ferraccioli
TAVOLA ROTONDA
Which future for public health care sustainability?
Regional scenarios, clinical needs and working hypothesis
Chairmen: Marcello Govoni, Ferrara - Giovanni Lapadula, Bari
11,45 – 12,05 National health care system and regional scenarios.
Anna Maria Marata, Modena
12,05 – 12,25 Clinical needs and expectancies.
Marcello Govoni, FerraraGISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
ECM PROGRAM
12,25 – 12,45 Are there suitable working hypothesis solutions?
Paolo Bonaretti, Reggio Emilia
Consulente del Ministero per lo Sviluppo Economico
13,45 – 14,30 Lunch
SESSION VI
Skin: a “Window of Opportunity”
CHAIRMEN:
Giovanni Lapadula, Fabrizio Conti, Rosario Foti
14,30 – 14,50 Il Progetto IDEA: final report
Fausto Salaffi, Ancona
14,50 – 15,20 Lettura
PsA e obesità.
Florenzo Iannone, Bari
15,20- 15,40 Skin and Psoriatic Arthritis.
Caterina Ferreli, Cagliari
15,40 – 16,00 Skin and Inflammatory Bowel Diseases.
Beatrice Principi, Bari
16,00 – 16,20 Skin and Rare Diseases.
Luca Cantarini, Siena
16,20 – 16,35 Discussion
ECM TESTGISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
CORSI MONOTEMATICI
THURSDAY 2TH MARCH
09,00 – 10,30 Sessione Corsi Monotematici No ECM
La Medicina Comunicazionale
Rosario Gagliardi, Lecce
Imaging del Paziente Complesso
Fausto Salaffi, Ancona
Marina Carotti, JesiGISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
SPONSORED LECTURES
THURSDAY 2TH MARCH
10,30 – 11,00 Sponsored Lecture - MSD
Golimumab persistence in therapy in real life:
new evidences from Italian registries
SPEAKER: Ennio Giulio Favalli, Milano
CHAIRMEN: Carlo Maurizio Montecucco
11,00 – 11,30 Sponsored Lecture - BMS
Efficacia di abatacept nella pratica clinica
SPEAKER: Florenzo Iannone, Bari
CHAIRMEN: Marcello Govoni
15,30 – 16,00 Sponsored Lecture - SANOFI
Quando l’anti-TNF in prima linea fallisce,
quali sono le possibili scelte da intraprendere
nel paziente affetto da AR (Artrite reumatoide)
SPEAKER: Ennio Giulio Favalli, Milano
CHAIRMEN: Leonardo Punzi, Luca Cantarini
16,00 – 16,30 Sponsored Lecture - ABBVIE
Occhio alle spondiloartropatie
SPEAKER: Luca Cimino, Reggio Emilia
CHAIRMEN: Andrea Doria, Enrico Fusaro
17,25 – 17,55 Sponsored Lecture - CELGENE
La gestione del paziente con artrite psoriasica
in assenza di fattori di prognosi severa
SPEAKER: Roberto Caporali, Pavia
CHAIRMEN: Giuseppe Passiu, Roberta RamondaGISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
SPONSORED LECTURES
FRIDAY 3TH MARCH
09,00 – 09,30 Sponsored Lecture - PFIZER
An innovative management of unmet needs
in RA (rheumatoid arthritis) patients to achieve
a Comprehensive Disease Control
SPEAKER: Fausto Salaffi, Ancona
CHAIRMEN: Oscar Massimiliano Epis, Walter Grassi
09,30 – 10,00 Sponsored Lecture - ROCHE
IL- 6 inhibition in RA: tocilizumab from RCT
to real world data.
SPEAKER: Marcello Govoni, Ferrara
CHAIRMEN: Giovanni Lapadula, Francesco Trotta
12,45 – 13,15 Sponsored Lecture - NOVARTIS
Secukinumab: tra la real life e i dati registrativi
SPEAKER: Giovanni Lapadula, Bari
CHAIRMEN: Marcello Govoni, Raffaele Pellerito
13,15 - 13,45 Sponsored Lecture - BIOGEN
Sostenibilità delle innovazioni farmacologiche: i biosimilari”
SPEAKER: Saverio Mennini, Roma
CHAIRMEN: Piercarlo Sarzi Puttini, Giovanni TrioloGISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
LINKS
BEST FOLLOWER 2017
A prize will be awarded to the medical postgraduate or young doctor
showing the most dedicated partecipation on the event’s social networks
Visit our website www.gisea.eu
Subscribe to Gruppo di Reumatologia • Registri GISEA/OEG,
visit our showcase page GISEA/OEG - Gruppo Italiano di Studio Early Arthritis
Visit our Facebook page Gruppo Italiano Studio Early Arthritis - Gisea/Org
Follow @Gisea_Oeg or search #gisea2017 to join the discussion
REGISTRATION FEE
The registration fee is € 500.00 + 22% VAT (€ 610,00 VAT included), payable by
bsnk transfer to th following account: Formedica Srl (IBAN CODE: IT 42 M 03268
16000 052668696720; SWIFT CODE: SELBIT2BXXX). Please send a copy of the
bank transfer (by fax: +39.0832.304994 or email: ecm@formedica.it)
to the Organizing Secretariat.GISEA/OEG FERRARA International Symposium 2017 2-3 MARZO 2017 ECM Continuing Medical Education (ECM) The GISEA International Symposium 2017 will be included in the ECM program of the Italian Ministry of Health as an educational amd residential activity (n.157- 179937) for no.100 participants (discipline: Rheumatology and Internal Medicine). The Symposium has obtained no. 9 Ecm credits. Credit assignement depends on the partecipation to th whole ECM training program,as detailed below: * TUESDAY 02th March: from 11.45 am to 3.30 pm and from 4.30 pm to 5.25 pm and from 5.55 pm to 7.10 pm. * FRIDAY 03th March: from 10.00 am to 12.45 pm and from 2.30 pm to 4.35 pm.. The participation of each attendee will be verified at the time of enetring and exiting throughout the duration of te Symposium. At the end of the ECM program, please com- plete the evaluation tests you have received during h regstration, and return them to the Secretariat. In order to acquire the ECM credits, please fill the registration form in all its partes clearly. An attendance certificat will be given to all participants at the end of the Symposium.
GISEA/OEG FERRARA
International Symposium 2017 2-3 MARZO 2017
SPONSORSHIP With the non conditional support of:
GOLDEN SPONSOR
GENZYMEGISEA/OEG FERRARA International Symposium 2017 2-3 MARZO 2017
Puoi anche leggere
